Communicated by Mark H. Paalman Alagille syndrome (AGS) is an autosomal dominant disorder with developmental abnormalities of the liver, heart, eyes, vertebrae, and face. Mutations in the JAG1 (Jagged 1) gene, coding a ligand in the evolutionarily conserved Notch signaling pathway, are responsible f
Spectrum ofJAG1gene mutations in Polish patients with Alagille syndrome
✍ Scribed by Jurkiewicz, Dorota; Gliwicz, Dorota; Ciara, Elżbieta; Gerfen, Jennifer; Pelc, Magdalena; Piekutowska-Abramczuk, Dorota; Kugaudo, Monika; Chrzanowska, Krystyna; Spinner, Nancy B.; Krajewska-Walasek, Małgorzata
- Book ID
- 125384752
- Publisher
- Springer-Verlag
- Year
- 2014
- Tongue
- English
- Weight
- 315 KB
- Volume
- 55
- Category
- Article
- ISSN
- 1234-1983
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Mutations in the human JAGGED1 gene cause Alagille syndrome, an autosomal dominant developmental disorder. The gene encodes a transmembrane protein which is a ligand of Notch receptors. We report 23 mutations in previously undescribed probands, including 15 novel mutations and 8 recurrent mutations.
Alagille syndrome (AGS) is caused by heterozygous mutations in JAG1, and mutations have been previously reported in about 70% of patients who meet clinical diagnostic criteria. We studied a cohort of 247 clinically well-defined patients, and using an aggressive and sequential screening approach we i
## Communicated by Riccardo Fodde Alagille syndrome (AGS) is an autosomal dominant disorder with developmental abnormalities affecting the liver, heart, eyes, vertebrae, and craniofacial region. The Jagged-1 (JAG1) gene, which encodes a ligand of Notch, has recently been found mutated in AGS. In th